Search

everythinglearnresearchcommunity

for

Search:↓

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Alcoholic solvent improves selectivity in key intermediate for finasteride and dutasteride synthesis.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Compound 7p shows strong potential as an anticancer agent.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Iron chloride helps create compounds that could be useful in medicine, like treating hair loss.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Certain drugs that block specific enzymes can help treat prostate diseases.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

A new compound shows promise as a topical treatment for hair loss.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.